Product Description |
Recombinant Human TNFRSF19 Protein is expressed from HEK293 with hFc tag at the C-Terminus.It contains Glu30-Leu170. |
Product Background |
A novel susceptibility gene TNFRSF19, which encodes an orphan member of the TNF receptor superfamily known to be associated with nasopharyngeal carcinoma (NPC) and lung cancer risk. TNFRSF19, a susceptibility gene for nasopharyngeal carcinoma and other cancers, functions as a potent inhibitor of the TGFβ signaling pathway. |
Product Category |
Recombinant Protein |
Target |
TNFRSF19 |
Synonyms |
TRADE; Toxicity and JNK inducer; Taj; Troy; AL023044; AW123854; TAJ-alpha; TAJ alpha |
Accession |
|
Species |
Human |
Biotinylated |
no |
Amino Acid Range |
Glu30-Leu170 |
Molecular Weight |
The protein has a predicted MW of 42.22 kDa. Due to glycosylation, the protein migrates to 50-60 kDa based on Bis-Tris PAGE result. |
Product Tag |
C-hFc |
Express System |
HEK293 |
Purity |
> 95% as determined by Bis-Tris PAGE;> 95% as determined by HPLC |
Endotoxin |
Less than 1EU per ug by the LAL method. |
Form |
Lyophilized |
Shipping |
Shipped at ambient temperature. |
Formulation |
Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Reconstitution |
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
Stability And Storage |
Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
|
Human TNFRSF19 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. |
|
|
The purity of Human TNFRSF19 is greater than 95% as determined by SEC-HPLC. |
Related Products
Have more questions?
Check out our Frequently Asked Questions page for more details about product specifications, ordering, and shipments.
Contact Us
Recently viewed
